Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q1 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $7.68 million versus the consensus estimate of $37.5 thousand.

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.